Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based combination therapy and gene therapy are new strategies to potentially overcome the limitations of TRAIL, however, the lack of efficient and low toxic vectors remains the major obstacle. In this study, we developed a hyaluronic ac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Deliv
Autors principals: Wang, Shengpeng, Shao, Min, Zhong, Zhangfeng, Wang, Anqi, Cao, Jiliang, Lu, Yucong, Wang, Yitao, Zhang, Jinming
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8240989/
https://ncbi.nlm.nih.gov/pubmed/29172759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1406558
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars